Inicio
Proyectos y Estudios
ESTUDIO RANDOMIZADO, FASE IIIB, DE TERAPIA DE DEPRIVACION ANDROGENICA INTERMITENTE VERSUS CONTINUA CON ELIGARD TRIMESTRAL 22,5 MG EN PACIENTES CON CANCER DE PROSTATA RECIDIVANTE Y LOCALMENTE AVANZADO, RESPONDEDORES A ESTA TERAPIA.

ESTUDIO RANDOMIZADO, FASE IIIB, DE TERAPIA DE DEPRIVACION ANDROGENICA INTERMITENTE VERSUS CONTINUA CON ELIGARD TRIMESTRAL 22,5 MG EN PACIENTES CON CANCER DE PROSTATA RECIDIVANTE Y LOCALMENTE AVANZADO, RESPONDEDORES A ESTA TERAPIA.

Datos básicos

Protocolo:: EGD-EC-003
EUDRACT:: 2005-004094-25
NCT:
Centro:
Año de incio:
Año de finalización:

ENSAYO CLÍNICO

Documentos

No hay documentos

Participantes

Juan Fernando Jimenez Cruz

Investigador Principal

Financiadores - Promotores

Astellas Pharma, S.A.

Resultados del Ensayo Clínico

Publicaciones en Revistas 10

Asymptotic modeling of electrochemical signaling: Testing Zn in urine for non-invasive bladder cancer diagnosis

Domenech-Carbo, A; (...); Ramos, D

Article. 10.1016/j.snb.2021.130646. 2021

Bladder cancer patients have increased NETosis and impaired DNaseI-mediated NET degradation that can be therapeutically restored in vitro.

Herranz R; (...); Medina P

Article. 10.3389/fimmu.2023.1171065. 2023

Effect of different schemes of androgen deprivation therapy on bone mass density in prostate cancer patients.

Arevalo Ruales, Karla; (...); Roman Ivorra, Jose Andres

Article. 10.1016/j.medcli.2022.03.026. 2023

Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs

Oto J; (...); Medina P

Article. 10.3390/ijms22157913. 2021

Long-Term Experience with Hyperthermic Chemotherapy (HIVEC) Using Mitomycin-C in Patients with Non-Muscle Invasive Bladder Cancer in Spain.

Plata A; (...); Angulo JC

Article. 10.3390/jcm10215105. 2021

Nuclear-medicine probes: Where we are and where we are going

Gonzalez-Montoro A; (...); Javier Gonzalez, Antonio

Article. 10.1002/mp.15690. 2022

Prostate cancer chemotherapy by intratumoral administration of Docetaxel-Mesoporous silica nanomedicines.

Rivero-Buceta, Eva; (...); Botella, Pablo

Article. 10.1016/j.ijpharm.2024.124623. 2024

Sildenafil Citrate Enhances Renal Organogenesis Following Metanephroi Allotransplantation into Non-Immunosuppressed Hosts.

Garcia-Dominguez, Ximo; (...); Marco-Jimenez, Francisco

Article. 10.3390/jcm11113068. 2022

The sentinel node with technetium-99m for prostate cancer. A safe and, mature new gold standard?

Perez-Ardavin J; (...); Vera-Donoso CD

Article. 10.23736/S1824-4785.22.03416-1. 2022

Validation of urine p-cresol glucuronide as renal cell carcinoma non-invasive biomarker

Oto, Julia; (...); Medina, Pilar

Article. 10.1016/j.jprot.2024.105357. 2025